P. D. de Verdier

发表

Genome-wide association study yields variants at 20p12.2 that associate with urinary bladder cancer.

Paolo Vineis, Simonetta Guarrera, Giuseppe Matullo, 2014, Human molecular genetics.

Diagnostic random bladder biopsies: Reflections from a population-based cohort of 538 patients

G. Steineck, P. Larsson, H. Wijkström, 2010, Scandinavian journal of urology and nephrology.

Polymorphisms in XPD, XPC and the risk of death in patients with urinary bladder neoplasms

K. Hemminki, Rajiv Kumar, G. Steineck, 2007, Acta oncologica.

Polymorphisms in NQO1 and the clinical course of urinary bladder neoplasms

K. Hemminki, Rajiv Kumar, G. Steineck, 2007, Scandinavian journal of urology and nephrology.

Effective treatment of mouse experimental colitis by alpha 2 integrin antibody: comparison with alpha 4 antibody and conventional therapy

L. Lindbom, P. Hellström, P. D. de Verdier, 2013, Acta physiologica.

Localization and expression of inducible nitric oxide synthase in patients after BCG treatment for bladder cancer.

P. D. de Verdier, N. Wiklund, M. Poljakovic, 2012, Nitric oxide : biology and chemistry.

Inhibition of sphingosine kinase 1 enhances cytotoxicity, ceramide levels and ROS formation in liver cancer cells treated with selenite.

J. Flygare, P. D. de Verdier, A. Rundlöf, 2012, Biochemical pharmacology.

Genotypes, haplotypes and diplotypes of three XPC polymorphisms in urinary-bladder cancer patients.

K. Hemminki, Rajiv Kumar, G. Steineck, 2010, Mutation research.

Outcome after BCG treatment for urinary bladder cancer may be influenced by polymorphisms in the NOS2 and NOS3 genes☆

G. Steineck, P. D. de Verdier, N. Wiklund, 2015, Redox biology.

Localization and expression of inducible nitric oxide synthase in biopsies from patients with interstitial cystitis.

P. D. de Verdier, N. Wiklund, I. Ehrén, 2008, The Journal of urology.

TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism

D. Schadendorf, K. Hemminki, Rajiv Kumar, 2013, Proceedings of the National Academy of Sciences.

Reactive Oxygen Species and Mitochondrial Sensitivity to Oxidative Stress Determine Induction of Cancer Cell Death by p21*

I. Roninson, S. Macip, P. Brennan, 2012, The Journal of Biological Chemistry.

Secondary stimulation from Bacillus Calmette-Guérin induced macrophages induce nitric oxide independent cell-death in bladder cancer cells.

J. Flygare, P. D. de Verdier, N. Wiklund, 2014, Cancer letters.

Protection of Cells in Physiological Oxygen Tensions against DNA Damage-induced Apoptosis*

Sam W. Lee, S. Aaronson, S. Macip, 2010, The Journal of Biological Chemistry.

FTY720 (Fingolimod) sensitizes hepatocellular carcinoma cells to sorafenib-mediated cytotoxicity

J. Flygare, P. D. de Verdier, P. Stål, 2015, Pharmacology research & perspectives.

Influence of polymorphism in DNA repair and defence genes on p53 mutations in bladder tumours.

K. Hemminki, Rajiv Kumar, G. Steineck, 2006, Cancer letters.

European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility gene.

Paolo Vineis, Abbas Ghaderi, Simonetta Guarrera, 2011, Human molecular genetics.

The Role of the HIF-1α Transcription Factor in Increased Cell Division at Physiological Oxygen Tensions

S. Macip, M. Althubiti, E. Hammond, 2014, PloS one.

Prostaglandin D2 effects and DP 1/DP 2 receptor distribution in guinea pig urinary bladder out‐flow region

P. D. de Verdier, N. Wiklund, L. Gustafsson, 2016, Journal of cellular and molecular medicine.

Polymorphisms in nitric-oxide synthase 3 may influence the risk of urinary-bladder cancer.

T. Nyberg, P. D. de Verdier, N. Wiklund, 2011, Nitric oxide : biology and chemistry.

Ser608Leu polymorphisms in the nitric oxide synthase-2 gene may influence urinary bladder cancer pathogenesis

T. Nyberg, P. D. de Verdier, N. Wiklund, 2011, Scandinavian journal of urology and nephrology.

Intravesical BCG treatment causes a long-lasting reduction of recurrence and progression in patients with high-risk non-muscle-invasive bladder cancer

G. Steineck, P. D. de Verdier, N. Wiklund, 2018, World Journal of Urology.

Localization of P2X receptor subtypes 2, 3 and 7 in human urinary bladder

P. D. de Verdier, N. Wiklund, M. Poljakovic, 2015, BMC Urology.

The (CCTTT)n microsatellite polymorphism in the nitric oxide synthase 2 gene may influence bladder cancer pathogenesis.

T. Nyberg, G. Steineck, P. D. de Verdier, 2010, The Journal of urology.

Mutations in TERT promoter and FGFR3 and telomere length in bladder cancer

K. Hemminki, Rajiv Kumar, G. Steineck, 2015, International journal of cancer.

Corrigendum: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer

L. Kiemeney, U. Thorsteinsdóttir, K. Stefánsson, 2009, Nature Genetics.